BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28068560)

  • 1. Effect of sarpogrelate, a selective 5-HT
    Lee DH; Chun EJ; Hur JH; Min SH; Lee JE; Oh TJ; Kim KM; Jang HC; Han SJ; Kang DK; Kim HJ; Lim S
    Atherosclerosis; 2017 Feb; 257():47-54. PubMed ID: 28068560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Statins on Coronary Atherosclerotic Plaques: The PARADIGM Study.
    Lee SE; Chang HJ; Sung JM; Park HB; Heo R; Rizvi A; Lin FY; Kumar A; Hadamitzky M; Kim YJ; Conte E; Andreini D; Pontone G; Budoff MJ; Gottlieb I; Lee BK; Chun EJ; Cademartiri F; Maffei E; Marques H; Leipsic JA; Shin S; Choi JH; Chinnaiyan K; Raff G; Virmani R; Samady H; Stone PH; Berman DS; Narula J; Shaw LJ; Bax JJ; Min JK
    JACC Cardiovasc Imaging; 2018 Oct; 11(10):1475-1484. PubMed ID: 29909109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cilostazol, a phosphodiesterase-3 inhibitor, on coronary artery stenosis and plaque characteristics in patients with type 2 diabetes: ESCAPE study.
    Lee DH; Chun EJ; Oh TJ; Kim KM; Moon JH; Choi SH; Park KS; Jang HC; Lim S
    Diabetes Obes Metab; 2019 Jun; 21(6):1409-1418. PubMed ID: 30761717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic implications of coronary CT angiography-derived quantitative markers for the prediction of major adverse cardiac events.
    Tesche C; Plank F; De Cecco CN; Duguay TM; Albrecht MH; Varga-Szemes A; Bayer RR; Yang J; Jacks IL; Gramer BM; Ebersberger U; Hoffmann E; Chiaramida SA; Feuchtner G; Schoepf UJ
    J Cardiovasc Comput Tomogr; 2016; 10(6):458-465. PubMed ID: 27522574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The additive effect of essential hypertension on coronary artery plaques in type 2 diabetes mellitus patients: a coronary computed tomography angiography study.
    Jiang Y; Li Y; Shi K; Wang J; Qian WL; Yan WF; Pang T; Yang ZG
    Cardiovasc Diabetol; 2022 Jan; 21(1):1. PubMed ID: 34983514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Association of Secondhand Tobacco Smoke and CT Angiography-Verified Coronary Atherosclerosis.
    Yankelevitz DF; Cham MD; Hecht H; Yip R; Shemesh J; Narula J; Henschke CI
    JACC Cardiovasc Imaging; 2017 Jun; 10(6):652-659. PubMed ID: 27852512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence and extent of coronary calcified plaque evaluated by coronary computed tomographic angiography are independent predictors of ischemic stroke in patients with suspected coronary artery disease.
    Lee H; Yoon YE; Kim YJ; Kim HL; Lee SP; Kim HK; Cho GY; Zo JH; Sohn DW
    Int J Cardiovasc Imaging; 2015 Oct; 31(7):1469-78. PubMed ID: 26179861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk classification of highly sensitive troponin I predict presence of vulnerable plaque assessed by dual source coronary computed tomography angiography.
    Liu T; Wang G; Li P; Dai X
    Int J Cardiovasc Imaging; 2017 Nov; 33(11):1831-1839. PubMed ID: 28528430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence, Characteristics, and Volumes of Coronary Plaque Determined by Computed Tomography Angiography in Young Type 2 Diabetes Mellitus.
    Nezarat N; Budoff MJ; Luo Y; Darabian S; Nakanishi R; Li D; Sheidaee N; Kim M; Alani A; Matsumoto S; Rahmani S; Kanisawa M; Ceponiene I; Osawa K; Qi H; Hamal S; Kitslaar P; Broersen A; Flores F; Ipp E; Khazai B
    Am J Cardiol; 2017 May; 119(10):1566-1571. PubMed ID: 28343599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study design of the influence of SErotonin inhibition on patients with RENAl impairment or diabetes undergoing drug-eluting stent implantation (SERENADE) study: A multicenter, open-label, prospective, randomized study.
    Lee SA; Suh JW; Park JJ; Yoon CH; Cho YS; Youn TJ; Chae IH; Kim HS; Kim SH; Choi DJ
    Contemp Clin Trials; 2015 Jul; 43():20-4. PubMed ID: 25891091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plaque progression assessed by a novel semi-automated quantitative plaque software on coronary computed tomography angiography between diabetes and non-diabetes patients: A propensity-score matching study.
    Nakanishi R; Ceponiene I; Osawa K; Luo Y; Kanisawa M; Megowan N; Nezarat N; Rahmani S; Broersen A; Kitslaar PH; Dailing C; Budoff MJ
    Atherosclerosis; 2016 Dec; 255():73-79. PubMed ID: 27835741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of Pooled-Cohort Equation and SCORE cardiovascular risk calculators to identify individuals with high coronary atherosclerotic burden - implications for statin treatment.
    Tralhão A; Ferreira AM; Gonçalves Pde A; Rodrigues R; Costa C; Guerreiro S; Cardim N; Marques H
    Coron Artery Dis; 2016 Nov; 27(7):573-9. PubMed ID: 27285280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between glycemic control and coronary artery disease severity, prevalence and plaque characteristics by computed tomography coronary angiography in asymptomatic type 2 diabetic patients.
    Tavares CA; Rassi CH; Fahel MG; Wajchenberg BL; Rochitte CE; Lerario AC
    Int J Cardiovasc Imaging; 2016 Oct; 32(10):1577-85. PubMed ID: 27432440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incremental prognostic value of quantitative plaque assessment in coronary CT angiography during 5 years of follow up.
    Nadjiri J; Hausleiter J; Jähnichen C; Will A; Hendrich E; Martinoff S; Hadamitzky M
    J Cardiovasc Comput Tomogr; 2016; 10(2):97-104. PubMed ID: 26837235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perivascular fat attenuation index and high-risk plaque features evaluated by coronary CT angiography: relationship with serum inflammatory marker level.
    Dai X; Deng J; Yu M; Lu Z; Shen C; Zhang J
    Int J Cardiovasc Imaging; 2020 Apr; 36(4):723-730. PubMed ID: 31907683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary Plaque Morphology and the Anti-Inflammatory Impact of Atorvastatin: A Multicenter 18F-Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Study.
    Singh P; Emami H; Subramanian S; Maurovich-Horvat P; Marincheva-Savcheva G; Medina HM; Abdelbaky A; Alon A; Shankar SS; Rudd JH; Fayad ZA; Hoffmann U; Tawakol A
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):e004195. PubMed ID: 27956407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential association between metabolic syndrome and coronary artery disease evaluated with cardiac computed tomography according to the presence of diabetes in a symptomatic Korean population.
    Won KB; Chang HJ; Sung J; Shin S; Cho IJ; Shim CY; Hong GR; Kim YJ; Choi BW; Chung N
    BMC Cardiovasc Disord; 2014 Aug; 14():105. PubMed ID: 25138993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of Dual-Source CT Coronary Angiography in Type 2 Diabetic Patients with Symptomatic Coronary Heart Disease.
    He C; Wang P; Du FZ; Yang ZG
    Curr Vasc Pharmacol; 2017; 15(1):59-65. PubMed ID: 27633455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High burden of coronary atherosclerosis in patients with a new diagnosis of type 2 diabetes.
    Mrgan M; Funck KL; Gaur S; Øvrehus KA; Dey D; Kusk MW; Nørgaard BL; Gram JB; Olsen MH; Gram J; Sand NPR
    Diab Vasc Dis Res; 2017 Nov; 14(6):468-476. PubMed ID: 28866908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pericardial fat volume and coronary atherosclerotic markers among body mass index groups.
    Hassan MB; Nafakhi H; Al-Mosawi AA
    Clin Cardiol; 2020 Sep; 43(9):993-998. PubMed ID: 32492245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.